Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Rentokil
RTO
|
+$510M |
| 2 |
Apellis Pharmaceuticals
APLS
|
+$205M |
| 3 |
TFI International
TFII
|
+$146M |
| 4 |
Ambev
ABEV
|
+$133M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$132M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.18B |
| 3 |
Mastercard
MA
|
+$3.67B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.38B |
| 5 |
Amazon
AMZN
|
+$3.16B |
Sector Composition
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.68% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Century Aluminum
CENX
$2.03B
| $89.5K | ﹤0.01% |
10,956
-10,956
| -50% | -$89.5K |
|
2352
indie Semiconductor
INDI
$804M
| $89.3K | ﹤0.01% |
15,322
-15,322
| -50% | -$89.3K |
|
2353
Accel Entertainment
ACEL
$936M
| $87.5K | ﹤0.01% |
11,370
-11,370
| -50% | -$87.5K |
|
2354
Atea Pharmaceuticals
AVIR
$251M
| $87.2K | ﹤0.01% |
18,140
-18,138
| -50% | -$87.2K |
|
2355
AvePoint
AVPT
$3.52B
| $87.1K | ﹤0.01% |
21,209
-21,209
| -50% | -$87.1K |
|
2356
Caribou Biosciences
CRBU
$171M
| $86K | ﹤0.01% |
13,678
-13,676
| -50% | -$86K |
|
2357
Aurinia Pharmaceuticals
AUPH
$1.63B
| $85.3K | ﹤0.01% |
19,712
-19,712
| -50% | -$85.3K |
|
2358
ATAI Life Sciences
ATAI
$1.05B
| $84.3K | ﹤0.01% |
31,939
-31,939
| -50% | -$84.3K |
|
2359
Bionano Genomics
BNGO
$20.5M
| $82.4K | ﹤0.01% |
94
-95
| -50% | -$83.3K |
|
2360
Vanda Pharmaceuticals
VNDA
$266M
| $82.3K | ﹤0.01% |
11,146
-11,146
| -50% | -$82.3K |
|
2361
Nektar Therapeutics
NKTR
$924M
| $82.3K | ﹤0.01% |
2,432
-2,431
| -50% | -$82.2K |
|
2362
IonQ
IONQ
$13.1B
| $80.2K | ﹤0.01% |
23,293
-23,297
| -50% | -$80.3K |
|
|
ME
2363
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $80.2K | ﹤0.01% |
1,861
-1,861
| -50% | -$80.2K |
|
|
RDFN
2364
DELISTED
Redfin
RDFN
| $80.2K | ﹤0.01% |
18,940
-18,940
| -50% | -$80.2K |
|
|
AGEN
2365
Agenus
AGEN
$162M
| $80.1K | ﹤0.01% |
1,704
-1,704
| -50% | -$80.1K |
|
|
VTNR
2366
DELISTED
Vertex Energy, Inc
VTNR
| $79.7K | ﹤0.01% |
+12,887
| New | +$79.7K |
|
2367
Carvana
CVNA
$51.8B
| $79.2K | ﹤0.01% |
16,718
-19,720
| -54% | -$93.4K |
|
2368
Kezar Life Sciences
KZR
$29.4M
| $79.1K | ﹤0.01% |
1,124
-1,123
| -50% | -$79K |
|
2369
Great Lakes Dredge & Dock
GLDD
$802M
| $78.6K | ﹤0.01% |
13,224
-13,224
| -50% | -$78.6K |
|
2370
Outdoor Holding Company Common Stock
POWW
$169M
| $78K | ﹤0.01% |
45,001
-46,495
| -51% | -$80.5K |
|
2371
Eventbrite
EB
$263M
| $77.8K | ﹤0.01% |
13,263
-13,263
| -50% | -$77.8K |
|
2372
Sangamo Therapeutics
SGMO
$157M
| $77.5K | ﹤0.01% |
24,731
-24,731
| -50% | -$77.5K |
|
2373
Riot Platforms
RIOT
$5.62B
| $77.5K | ﹤0.01% |
22,885
-22,885
| -50% | -$77.5K |
|
2374
Gevo
GEVO
$389M
| $77K | ﹤0.01% |
40,428
-40,428
| -50% | -$77K |
|
2375
GoodRx Holdings
GDRX
$1.43B
| $76.9K | ﹤0.01% |
16,519
-16,517
| -50% | -$76.9K |
|